Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001237334-26-000003

Director sold 1,000 shares at $520.00 ($520,000)

  • Director acquired 1,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

CAUSEY CHRISTOPHER · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-25 Exercise or conversion : show line 1 in the form 10b5-1 +1,000 $119.76 $119,760 5,190 D
2026-02-25 Sale : show line 2 in the form 10b5-1 −1,000 $520.00 $520,000 4,190 D
Open-market sales · 1,000 sh · avg $520.00 · $520,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-25 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option −1,000 6,320 D
Loading xslF345X05/primarydocument.xml…